Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its financial results for the second quarter ending June 30, 2020, on August 5, 2020, before the market opens. A conference call will take place the same day at 8:00 a.m. Eastern Time, accessible via toll-free and international numbers with a conference ID of #4458189. The call will also be webcast on the company’s investor relations website. Harvard Bioscience specializes in technologies for fundamental research and drug development, serving academic institutions, government labs, and leading pharmaceutical firms across North America and Europe.
- Upcoming financial results announcement for Q2 2020.
- Conference call scheduled for August 5, 2020, demonstrating transparency with investors.
- None.
HOLLISTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2020 before the market opens on August 5, 2020, and will hold a conference call to discuss the results on August 5, 2020 at 8:00 a.m. Eastern Time.
You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 4458189.
The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations. The webcast will be available on the website through August 12, 2020.
Financial information presented on the call, including the earnings release, will be available on the investor relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and clinical research organizations. With operations in North America and Europe, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Investor Contact
Michael Rossi
Chief Financial Officer
(508) 893-8999
mrossi@harvardbioscience.com
FAQ
When will Harvard Bioscience announce its Q2 2020 financial results?
What time is the conference call for Harvard Bioscience's Q2 2020 results?
How can I access the Harvard Bioscience conference call?
Where can I find the webcast for Harvard Bioscience's conference call?
